Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics, Inc. - Common Stock (NQ: CARA )

5.200 -0.400 (-7.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Marijuana Stock Movers For June 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
S&P 500 Edges Higher; J.Jill Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Analyst Ratings For Cara Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers'
Cara Therapeutics plans to explore strategic alternatives. There are no meaningful development programs in the pipeline, analysts note. 
Via Benzinga
Gold Down 1%; Broadcom Shares Jump After Upbeat Results
Via Benzinga
Williams-Sonoma Stock Split: Mark Your Calendars for June 27
Williams-Sonoma is preparing for a stock split through dividend with the cutoff date for WSM shareholders set for June 27. 
Via InvestorPlace
Dow Tumbles Over 100 Points; US Producer Prices Decline In May
Via Benzinga
Topics Stocks
Exposures US Equities
In-Depth Examination Of 5 Analyst Recommendations For Cara Therapeutics
Via Benzinga
Why Is Cara Therapeutics (CARA) Stock Down 27% Today?
Cara Therapeutics stock is down on Thursday as investors learn of a failed clinical trial and the company considering strategic alternatives. 
Via InvestorPlace
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday as we break down all of the hottest stock market news this morning! 
Via InvestorPlace
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Gainers And Losers From June 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 6, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 5, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 3, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 31, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For May 30, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For May 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For May 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For May 17, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
CARA Stock Earnings: Cara Therapeutics Misses EPS, Beats Revenue for Q1 2024
CARA stock results show that Cara Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Cara Therapeutics Reports First Quarter 2024 Financial Results
Topline efficacy and safety results from KOURAGE 1 Part A portion of notalgia paresthetica (NP) pivotal program now expected by the end of 2Q24 
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
From Cara Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.